Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience by Dario Cattaneo, Marta Fusi, Marta Colaneri, Chiara Fusetti, Camilla Genovese, Riccardo Giorgi, Maddalena Matone, Stefania Merli, Francesco Petri, Andrea Gori

Get full text

Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study by Simona Biscarini, Simone Villa, Camilla Genovese, Mara Tomasello, Anna Tonizzo, Marco Fava, Nathalie Iannotti, Matteo Bolis, Bianca Mariani, Antonia Grazia Valzano, Letizia Corinna Morlacchi, Francesca Donato, Giuseppe Castellano, Ramona Cassin, Maria Carrabba, Antonio Muscatello, Andrea Gori, Alessandra Bandera, Andrea Lombardi

Get full text

Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immuno... by Andrea Lombardi, Giulia Viero, Simone Villa, Simona Biscarini, Emanuele Palomba, Cecilia Azzarà, Nathalie Iannotti, Bianca Mariani, Camilla Genovese, Mara Tomasello, Anna Tonizzo, Marco Fava, Antonia Grazia Valzano, Letizia Corinna Morlacchi, Maria Francesca Donato, Giuseppe Castellano, Ramona Cassin, Maria Carrabba, Antonio Muscatello, Andrea Gori, Alessandra Bandera

Get full text

What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres by Agnese Comelli, Camilla Genovese, Andrea Lombardi, Chiara Bobbio, Luigia Scudeller, Umberto Restelli, Antonio Muscatello, Spinello Antinori, Paolo Bonfanti, Salvatore Casari, Antonella Castagna, Francesco Castelli, Antonella d’Arminio Monforte, Fabio Franzetti, Paolo Grossi, Matteo Lupi, Paola Morelli, Stefania Piconi, Massimo Puoti, Luigi Pusterla, Angelo Regazzetti, Marco Rizzi, Stefano Rusconi, Valentina Zuccaro, Andrea Gori, Alessandra Bandera, the ASP Lomb Study Group

Get full text